๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐๐ซ๐ฎ ๐๐ง-๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ก๐ ๐๐๐ซ๐ฎ ๐๐ง-๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.
๐๐๐ฒ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ :
๐๐ข๐ฌ๐ข๐ง๐ ๐๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.
๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.
๐๐ฆ๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.
https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
๐๐ก๐ ๐๐๐ซ๐ฎ ๐๐ง-๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.
๐๐๐ฒ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ :
๐๐ข๐ฌ๐ข๐ง๐ ๐๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.
๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.
๐๐ฆ๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.
https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐๐ซ๐ฎ ๐๐ง-๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ
๐๐ก๐ ๐๐๐ซ๐ฎ ๐๐ง-๐๐ข๐ญ๐ซ๐จ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ size is predicted to reach USD 163.3 million at a CAGR of 2.4% till 2030. In-Vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions.
๐๐๐ฒ ๐๐ซ๐จ๐ฐ๐ญ๐ก ๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ :
๐๐ข๐ฌ๐ข๐ง๐ ๐๐ซ๐๐ฏ๐๐ฅ๐๐ง๐๐ ๐จ๐ ๐๐ก๐ซ๐จ๐ง๐ข๐ ๐๐ข๐ฌ๐๐๐ฌ๐๐ฌ : The increasing incidence of chronic conditions, such as cancer, is driving the need for early detection and personalized treatment, leading to a surge in the adoption of advanced IVD technologies.
๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐๐๐ฅ ๐๐๐ฏ๐๐ง๐๐๐ฆ๐๐ง๐ญ๐ฌ : The introduction of point-of-care testing (POCT) solutions is enhancing the efficiency of disease detection and management, particularly in remote and underserved areas, contributing to market growth.
๐๐ฆ๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐จ๐ฐ๐ญ๐ก : Peru's demand for diagnostic reagents is on the rise, with imports expected to reach nearly USD 75 million by 2028, up from USD 63 million in 2023, indicating an average annual growth rate of 2.7%.
https://www.nextmsc.com/report/peru-in-vitro-diagnostics-market
0 Commenti
0 condivisioni
53 Views
0 Anteprima